💸 The Tape

Organigram Unleashes Edison Sonics

Grab your hats because Organigram Holdings Inc. (NASDAQ: OGI) is shaking up the cannabis world with the launch of Edison Sonics gummies, powered by their groundbreaking nanoemulsion technology, FAST™. These gummies are not your average edibles; they promise up to 50% faster onset and nearly double the cannabinoids at peak effect. Think of it as the Ferrari of cannabis edibles.

FAST™ technology, short for Fast Acting Soluble Technology, breaks down cannabinoids into tiny particles for quicker and more efficient absorption. This innovation has been scientifically validated through one of the largest pharmacokinetic studies in the cannabis industry. It’s like turning your gummies into high-speed trains of euphoria.

Borna Zlamalik, Organigram’s Senior VP of R&D and Innovation, is stoked about this launch, calling Edison Sonics a game-changer. And why wouldn't he be? These gummies are poised to revolutionize the edibles category and redefine the cannabis experience.

Launched with two tantalizing flavors—Kiwi Berry Burst (Sativa) and Red Razz Chiller (Indica)—these gummies are set to hit all major provinces in early December. Each pack includes two gummies with a total of 10mg THC and 10mg CBD, ensuring a balanced and potent experience.

CEO Beena Goldenberg highlights Organigram’s commitment to consumer-focused innovation, a trait that has set the company apart in a fiercely competitive industry. With products like Rip Strip Hash and first-to-market Edison JOLTS, Organigram continues to push boundaries and deliver revolutionary products.

Edison, inspired by scientific discoveries and a spirit of playful experimentation, aims to bring joy and excitement back to cannabis. With Edison Sonics Gummies, they're not just raising the bar—they’re catapulting it into the stratosphere.

So, if you’re ready for a cannabis experience that’s fast, effective, and downright delicious, keep an eye out for Edison Sonics. Organigram’s latest innovation is set to be a hit among cannabis enthusiasts and a testament to the company’s leading edge in the market. 

📈 Dog Walkers

GTI Gets A Cashish Injection

Green Thumb Industries Inc. (CSE: GTII, OTCQX: GTBIF) just announced a tidy windfall from a prior loan to Cansortium Inc., netting approximately $23 million of principal plus 13% accrued interest. This boosts their Q3 ending cash balance to a robust $174 million. CEO Ben Kovler, ever the shrewd financial strategist, congratulated Cansortium on their recent move and highlighted Green Thumb's opportunistic investment approach. Kovler's strategy of seeking upside optionality with downside protection paid off, literally, at 100 cents on the dollar. As the cannabis market continues to bloom, Green Thumb is primed to reinvest these funds into new opportunities, keeping their shareholders smiling.

C21 Initiates Buyback Program

C21 Investments Inc. (CSE: CXXI, OTCQX: CXXIF) is gearing up to repurchase up to 6,002,390 common shares, representing about 5% of its outstanding shares, through a normal course issuer bid (NCIB). Kicking off December 2, 2024, and running until December 2, 2025, these shares will be scooped up on the Canadian Securities Exchange at market prices. The buyback will be funded with cash on hand, and shares snagged will be promptly canceled. By gobbling up its own stock, C21 aims to bolster shareholder value, asserting that the current market price undervalues its business prospects.

Cansortium Closes Major Credit Facility

Cansortium Inc. (CSE: TIUM.U, OTCQB: CNTMF) just closed a hefty $96.5 million senior secured credit agreement with Chicago Atlantic Admin, LLC. Sporting a cash interest rate of 12.00% and a PIK interest of 1.00% per annum, this deal refinances their existing $71 million term loan, nixing the $10 million prepayment requirement. CEO Robert Beasley is all smiles, highlighting the non-dilutive structure preserving shareholder value and zero major debt maturities until late 2028. With additional credit lines totaling $25 million and cash inflow from the RIV Capital combination, Cansortium is ready to ramp up strategic acquisitions and growth initiatives in key markets.

🗞️ The News

DEA Posts Details On Next Week’s Marijuana Rescheduling Hearing, Including Live Stream And Documents Portal

Federal Health Officials ‘Rejected’ DEA’s Request To Testify At Marijuana Rescheduling Hearing, Agency Tells Judge

C21 Investments Announces Normal Course Issuer Bid

Green Thumb Industries Repaid on Cansortium Loan

Organigram Launches FAST™ Nanoemulsion Gummies

Canopy Growth Announces Mr. Luc Mongeau As The Company's Next CEO

📺 YouTube

Trump Administration’s Potential Approach to Cannabis Reform | Trade to Black

What we covered:

✅ In the latest Trade of Black Evergreen Mini video, host Shadd Dales explains what cannabis policy reform could look like under a renewed Trump administration.

Following the 2024 elections, with Republicans controlling the Senate and Trump back in the White House, the political landscape could favor progress on cannabis reform. Key initiatives like the SAFE Banking Act may gain traction, offering cannabis businesses access to financial services while addressing public safety concerns.

The appointments of Pam Bondi as Attorney General and Robert F. Kennedy Jr. as Secretary of Health and Human Services could further shape reform efforts. Bondi’s pragmatic approach could emphasize regulating cannabis banking to reduce crime, while Kennedy’s openness to alternative therapies might lead to rescheduling cannabis, unlocking its medical potential.

With growing bipartisan support and examples of economic success in Republican-led states, this administration could spearhead historic changes in U.S. cannabis policy.